共查询到20条相似文献,搜索用时 15 毫秒
1.
Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k 总被引:2,自引:0,他引:2
Tavares FX Boncek V Deaton DN Hassell AM Long ST Miller AB Payne AA Miller LR Shewchuk LM Wells-Knecht K Willard DH Wright LL Zhou HQ 《Journal of medicinal chemistry》2004,47(3):588-599
Osteoclast-mediated bone matrix resorption has been attributed to cathepsin K, a cysteine protease of the papain family that is abundantly and selectively expressed in osteoclast. Inhibition of cathepsin K could potentially be an effective method to prevent osteoporosis. Structure-activity studies on a series of reversible ketoamides based inhibitors of cathepsin K have led to identification of potent and selective compounds. Crystallographic studies have given insights into the mode of binding of these inhibitors. A series of ketoamides with varying P1 moieties were first synthesized to find an optimum group that would fit into the S1 subsite of the cysteine protease, cathepsin K. With a desired P1 group in place a variety of heterocyclic analogues in the P' region were synthesized to study their steric and electronic effects. In the process of exploring these P' heterocyclic variations, excellent selectivity was gained over other highly homologous cysteine proteases, including cathepsins L, S, and V. The favorable pharmacokinetic properties of some of these cathepsin K inhibitors in rats make them suitable for evaluation in rodent osteoporosis models. A representative cathepsin K inhibitor was shown to attenuate PTH-stimulated hypercalcemia in the TPTX rat model. These inhibitors provide a viable lead series in the discovery of new therapies for the prevention and treatment of osteoporosis 相似文献
2.
A M Doherty I Sircar B E Kornberg J Quin R T Winters J S Kaltenbronn M D Taylor B L Batley S R Rapundalo M J Ryan 《Journal of medicinal chemistry》1992,35(1):2-14
A series of primate renin inhibitors containing difluorocarbinol and difluoroketone groups at the P1-P1' position have been synthesized and studied both in vitro and in vivo. In vitro, the compounds were evaluated as inhibitors of monkey renin and the closely related aspartic proteinase, cathepsin D (bovine), as a measure of enzyme selectivity. Interestingly, the difluoroketone derivatives showed greatly reduced selectivity compared with the corresponding alcohols. However, selectivity could be enhanced by judicious choice of other substituents. Sites influencing selectivity, included not only P2, which is well-known to strongly affect selectivity, but also the P4, P1-P1', and P2' sites. These results make possible the design of inhibitors with a greater selectivity for either renin versus cathepsin D. In vivo several of the compounds in the difluoroketone series have shown good oral activity in the salt depleted normotensive cynomolgus monkey model. 相似文献
3.
4.
Prime ME Courtney SM Brookfield FA Marston RW Walker V Warne J Boyd AE Kairies NA von der Saal W Limberg A Georges G Engh RA Goller B Rueger P Rueth M 《Journal of medicinal chemistry》2011,54(1):312-319
The inhibition of Aurora kinases in order to arrest mitosis and subsequently inhibit tumor growth via apoptosis of proliferating cells has generated significant discussion within the literature. We report a novel class of Aurora kinase inhibitors based upon a phthalazinone pyrazole scaffold. The development of the phthalazinone template resulted in a potent Aurora-A selective series of compounds (typically >1000-fold selectivity over Aurora-B) that display good pharmacological profiles with significantly improved oral bioavailability compared to the well studied Aurora inhibitor VX-680. 相似文献
5.
AE Kümmerle M Schmitt SV Cardozo C Lugnier P Villa AB Lopes NC Romeiro H Justiniano MA Martins CA Fraga JJ Bourguignon EJ Barreiro 《Journal of medicinal chemistry》2012,55(17):7525-7545
Among a small series of tested N-acylhydrazones (NAHs), the compound 8a was selected as a selective submicromolar phosphodiesterase-4 (PDE4) inhibitor associated with anti-TNF-α properties measured both in vitro and in vivo. The recognition pattern of compound 8a was elucidated through molecular modeling studies based on the knowledge of the 3D-structure of zardaverine, a PDE4 inhibitor resembling the structure of 8a, cocrystallized with the PDE4. Based on further conformational analysis dealing with N-methyl-NAHs, a quinazoline derivative (19) was designed as a conformationally constrained NAH analogue and showed similar in vitro pharmacological profile, compared with 8a. In addition 19 was found active when tested orally in LPS-evoked airway hyperreactivity and fully confirmed the working hypothesis supporting this work. 相似文献
6.
Leonetti F Favia A Rao A Aliano R Paluszcak A Hartmann RW Carotti A 《Journal of medicinal chemistry》2004,47(27):6792-6803
The design, synthesis, and biological evaluation of a series of new aromatase inhibitors bearing an imidazole or triazole ring linked to a fluorene (A), indenodiazine (B), or coumarin scaffold (C) are reported. Properly substituted coumarin derivatives displayed the highest aromatase inhibitory potency and selectivity over 17-alpha-hydroxylase/17-20 lyase. The modeling of the aromatase inhibition data by Comparative Molecular Field Analysis (CoMFA/GOLPE 3D QSAR approach) led to the development of a PLS model with good fitting and predictive powers (n = 22, ONC = 3, r(2) = 0.949, s = 0.216, and q(2) = 0.715). The relationship between aromatase inhibition and the steric and electrostatic fields generated by the examined azole inhibitors enables a clear understanding of the nature and spatial location of the main interactions modulating the aromatase inhibitory potency. 相似文献
7.
Muraglia E Kinzel O Gardelli C Crescenzi B Donghi M Ferrara M Nizi E Orvieto F Pescatore G Laufer R Gonzalez-Paz O Di Marco A Fiore F Monteagudo E Fonsi M Felock PJ Rowley M Summa V 《Journal of medicinal chemistry》2008,51(4):861-874
HIV integrase is one of the three enzymes encoded by HIV genome and is essential for viral replication, but integrase inhibitors as marketed drugs have just very recently started to emerge. In this study, we show the evolution from the N-methylpyrimidinone structure to bicyclic pyrimidinones. Introduction of a suitably substituted amino moiety modulated the physical-chemical properties of the molecules and conferred nanomolar activity in the inhibition of spread of HIV-1 infection in cell culture. An extensive SAR study led to sulfamide (R)- 22b, which inhibited the strand transfer with an IC50 of 7 nM and HIV infection in MT4 cells with a CIC95 of 44 nM, and ketoamide (S)- 28c that inhibited strand transfer with an IC50 of 12 nM and the HIV infection in MT4 cells with a CIC95 of 13 nM and exhibited a good pharmacokinetic profile when dosed orally to preclinical species. 相似文献
8.
Johnson TW Tanis SP Butler SL Dalvie D Delisle DM Dress KR Flahive EJ Hu Q Kuehler JE Kuki A Liu W McClellan GA Peng Q Plewe MB Richardson PF Smith GL Solowiej J Tran KT Wang H Yu X Zhang J Zhu H 《Journal of medicinal chemistry》2011,54(9):3393-3417
HIV-1 integrase (IN) is one of three enzymes encoded by the HIV genome and is essential for viral replication, and HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Recently, we reported the synthesis of orally bioavailable azaindole hydroxamic acids that were potent inhibitors of the HIV-1 IN enzyme. Here we disclose the design and synthesis of novel tricyclic N-hydroxy-dihydronaphthyridinones as potent, orally bioavailable HIV-1 integrase inhibitors displaying excellent ligand and lipophilic efficiencies. 相似文献
9.
N J Liverton J W Butcher C F Claiborne D A Claremon B E Libby K T Nguyen S M Pitzenberger H G Selnick G R Smith A Tebben J P Vacca S L Varga L Agarwal K Dancheck A J Forsyth D S Fletcher B Frantz W A Hanlon C F Harper S J Hofsess M Kostura J Lin S Luell E A O'Neill S J O'Keefe 《Journal of medicinal chemistry》1999,42(12):2180-2190
Novel potent and selective diarylimidazole inhibitors of p38 MAP (mitogen-activated protein) kinase are described which have activity in both cell-based assays of tumor necrosis factor-alpha (TNF-alpha) release and an animal model of rheumatoid arthritis. The SAR leading to the development of selectivity against c-Raf and JNK2alpha1 kinases is presented, with key features being substitution of the 4-aryl ring with m-trifluoromethyl and substitution of the 5-heteroaryl ring with a 2-amino substituent. Cell-based activity was significantly enhanced by incorporation of a 4-piperidinyl moiety at the 2-position of the imidazole which also enhanced aqueous solubility. In general, oral bioavailability of this class of compounds was found to be poor unless the imidazole was methylated on nitrogen. This work led to identification of 48, a potent (p38 MAP kinase inhibition IC50 0.24 nM) and selective p38 MAP kinase inhibitor which inhibits lipopolysaccharide-stimulated release of TNF-alpha from human blood with an IC50 2.2 nM, shows good oral bioavailability in rat and rhesus monkey, and demonstrates significant improvement in measures of disease progression in a rat adjuvant-induced arthritis model. 相似文献
10.
Cee VJ Albrecht BK Geuns-Meyer S Hughes P Bellon S Bready J Caenepeel S Chaffee SC Coxon A Emery M Fretland J Gallant P Gu Y Hodous BL Hoffman D Johnson RE Kendall R Kim JL Long AM McGowan D Morrison M Olivieri PR Patel VF Polverino A Powers D Rose P Wang L Zhao H 《Journal of medicinal chemistry》2007,50(4):627-640
The recognition that aberrant angiogenesis contributes to the pathology of inflammatory diseases, cancer, and myocardial ischemia has generated considerable interest in the molecular mechanisms that regulate blood vessel growth. The receptor tyrosine kinase Tie-2 is expressed primarily by vascular endothelial cells and is critical for embryonic vasculogenesis. Interference with the Tie-2 pathway by diverse blocking agents such as soluble Tie-2 receptors, anti-Tie-2 intrabodies, anti-Ang-2 antibodies, and peptide-Fc conjugates has been shown to suppress tumor growth in xenograft studies. An alternative strategy for interfering with the Tie-2 signaling pathway involves direct inhibition of the kinase functions of the Tie-2 receptor. Herein we describe the development of alkynylpyrimidine amide derivatives as potent, selective, and orally available ATP-competitive inhibitors of Tie-2 autophosphorylation. 相似文献
11.
Malamas MS Ni Y Erdei J Stange H Schindler R Lankau HJ Grunwald C Fan KY Parris K Langen B Egerland U Hage T Marquis KL Grauer S Brennan J Navarra R Graf R Harrison BL Robichaud A Kronbach T Pangalos MN Hoefgen N Brandon NJ 《Journal of medicinal chemistry》2011,54(21):7621-7638
The identification of highly potent and orally active phenylpyrazines for the inhibition of PDE10A is reported. The new analogues exhibit subnanomolar potency for PDE10A, demonstrate high selectivity against all other members of the PDE family, and show desired druglike properties. Employing structure-based drug design approaches, we methodically explored two key regions of the binding pocket of the PDE10A enzyme to alter the planarity of the parent compound 1 and optimize its affinity for PDE10A. Bulky substituents at the C9 position led to elimination of the mutagenicity of 1, while a crucial hydrogen bond interaction with Glu716 markedly enhanced its potency and selectivity. A systematic assessment of the ADME and PK properties of the new analogues led to druglike development candidates. One of the more potent compounds, 96, displayed an IC(50) for PDE10A of 0.7 nM and was active in predictive antipsychotic animal models. 相似文献
12.
Osteoporosis is a disease characterized by skeletal fragility. Cathepsin K, a lysosomal cysteine protease, has been implicated in the osteoclast mediated bone resorption. Inhibitors of this protease could potentially treat this skeletal disease. The present work describes exploration of the spatial requirements of the S3 subsite by the use of various sterically demanding P3 substituents. Sulfur and oxygen linked heterocycles as well as those without heteroatom linkers were found to provide potent inhibitors of cathepsin K. Representative examples from these series also afforded quite good selectivity ratios against most cathepsins tested. The tolerability of the S3 subsite for sterically demanding groups that provide potency and selectivity enhances the attractiveness of P3 changes to improve the physiochemical properties of inhibitors in the developments of compounds for the treatment of osteoporosis. 相似文献
13.
Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors 总被引:1,自引:0,他引:1
Liu G Lynch JK Freeman J Liu B Xin Z Zhao H Serby MD Kym PR Suhar TS Smith HT Cao N Yang R Janis RS Krauser JA Cepa SP Beno DW Sham HL Collins CA Surowy TK Camp HS 《Journal of medicinal chemistry》2007,50(13):3086-3100
Stearoyl-CoA desaturase 1 (SCD1) catalyzes the committed step in the biosynthesis of monounsaturated fatty acids from saturated, long-chain fatty acids. Studies with SCD1 knockout mice have established that these animals are lean and protected from leptin deficiency-induced and diet-induced obesity, with greater whole body insulin sensitivity than wild-type animals. In this work, we have discovered a series of potent, selective, orally bioavailable SCD1 inhibitors based on a known pyridazine carboxamide template. The representative lead inhibitor 28c also demonstrates excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells. 相似文献
14.
Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. 总被引:3,自引:0,他引:3
Sanghee Kim Hyojin Ko Jae Eun Park Sungkyu Jung Sang Kwang Lee Young-Jin Chun 《Journal of medicinal chemistry》2002,45(1):160-164
A series of trans-stilbene derivatives containing a 3,5-dimethoxyphenyl moiety were prepared through a new efficient solution phase synthetic pathway, and their inhibitory activities were evaluated on human cytochrome P450s (CYP) 1A1, 1A2, and 1B1 to find a potent and selective CYP1B1 inhibitor. We found that a substituent at the 2-position of the stilbene skeleton plays a very important role in discriminating between CYP1As and CYP1B1. Among the compounds tested, the most selective and potent CYP1B1 inhibitor was 2,3',4,5'-tetramethoxystilbene. Compound 7j, 2-[2-(3,5-dimethoxy-phenyl)vinyl]thiophene, showed greater inhibitory activities but had a lower selectivity toward all of the CYP1s tested. 相似文献
15.
Tavares FX Deaton DN Miller AB Miller LR Wright LL Zhou HQ 《Journal of medicinal chemistry》2004,47(21):5049-5056
Cathepsin K, a lysosomal cysteine protease of the papain superfamily, is abundantly and selectively expressed in osteoclasts, suggesting that this enzyme is crucial for bone resorption. Prevention of osteoclast-mediated bone resorption via inhibition of cathepsin K could be an effective approach to prevent osteoporosis. Potent and selective reversible ketoamide-based inhibitors have been identified in the present study. Using a known crystal structure of a ketoamide-based inhibitor, information from residues that form the P2/P3 pocket was used in the design of inhibitors that could allow for gains in selectivity and potency. Further, incorporation of P' selective heterocycles, along with the P2/P3 modifications, is also described. These modifications have resulted in potent and selective cathepsin K inhibitors that allow for improvements in their physiochemical properties and represent a viable lead series for the discovery of new therapies for the prevention and treatment of osteoporosis 相似文献
16.
Robert S Bertolla C Masereel B Dogné JM Pochet L 《Journal of medicinal chemistry》2008,51(11):3077-3080
Recently, FXIIa was highlighted as an original attractive target for the development of new anticoagulant drugs with low rates of therapy-related hemorrhages. In this work, we describe the development of a new series of 3-carboxamide-coumarins that are the first potent and selective nonpeptidic inhibitors of FXIIa. 相似文献
17.
Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers. 总被引:1,自引:0,他引:1
J Lloyd J B Schmidt G Rovnyak S Ahmad K S Atwal S N Bisaha L M Doweyko P D Stein S C Traeger A Mathur M L Conder J DiMarco T W Harper T Jenkins-West P C Levesque D E Normandin A D Russell R P Serafino M A Smith N J Lodge 《Journal of medicinal chemistry》2001,44(23):3764-3767
Multiple delayed rectifier potassium currents, including I(Ks), are responsible for the repolarization and termination of the cardiac action potential, and blockers of these currents may be useful as antiarrhythmic agents. Modification of compound 5 produced 19(S) that is the most potent I(Ks) blocker reported to date with >5000-fold selectivity over other cardiac ion channels. Further modification produced 24A with 23% oral bioavailability. 相似文献
18.
Senten K Van der Veken P De Meester I Lambeir AM Scharpé S Haemers A Augustyns K 《Journal of medicinal chemistry》2003,46(23):5005-5014
In this paper we report the systematic search for new, potent, and selective DPP II inhibitors. A study of the structure-activity relationship was conducted starting from aminoacyl pyrrolidides as lead compounds. Rational exploration of the P(1) and P(2) building blocks led to the discovery of some very potent DPP II inhibitors which can be characterized by their high selectivity for DPP II with regard to DPP IV. Dab-Pip and Dab-Pip-2-CN were selected as the most promising inhibitors (IC(50) nM range) and will enable us to study the physiological role of DPP II and to differentiate between DPP II and DPP IV in biological systems. 相似文献
19.
Carol K Wada James H Holms Michael L Curtin Yujia Dai Alan S Florjancic Robert B Garland Yan Guo H Robin Heyman Jamie R Stacey Douglas H Steinman Daniel H Albert Jennifer J Bouska Ildiko N Elmore Carole L Goodfellow Patrick A Marcotte Paul Tapang Douglas W Morgan Michael R Michaelides Steven K Davidsen 《Journal of medicinal chemistry》2002,45(1):219-232
A novel series of sulfone N-formylhydroxylamines (retrohydroxamates) have been investigated as matrix metalloproteinases (MMP) inhibitors. The substitution of the ether linkage of ABT-770 (5) with a sulfone group 13a led to a substantial increase in activity against MMP-9 but was accompanied by a loss of selectivity for inhibition of MMP-2 and -9 over MMP-1 and diminished oral exposure. Replacement of the biphenyl P1' substituent with a phenoxyphenyl group provided compounds that are highly selective for inhibition of MMP-2 and -9 over MMP-1. Optimization of the substituent adjacent to the retrohydroxamate center in this series led to the clinical candidate ABT-518 (6), a highly potent, selective, orally bioavailable MMP inhibitor that has been shown to significantly inhibit tumor growth in animal cancer models. 相似文献
20.
Hu E Tasker A White RD Kunz RK Human J Chen N Bürli R Hungate R Novak P Itano A Zhang X Yu V Nguyen Y Tudor Y Plant M Flynn S Xu Y Meagher KL Whittington DA Ng GY 《Journal of medicinal chemistry》2008,51(11):3065-3068
Inhibition of c-Kit has the potential to treat mast cell associated fibrotic diseases. We report the discovery of several aminoquinazoline pyridones that are potent inhibitors of c-Kit with greater than 200-fold selectivity against KDR, p38, Lck, and Src. In vivo efficacy of pyridone 16 by dose-dependent inhibition of histamine release was demonstrated in a rodent pharmacodynamic model of mast cell activation. 相似文献